Increased suicide attempt rate among patients interrupting use of atypical antipsychotics.
about
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating OverviewLinking community pharmacy dispensing data to prescribing data of general practitioners.Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand.An episode-based framework for analyzing health care expenditures: an application of reward renewal models.Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nursesIs clozapine antisuicidal?Paliperidone palmitate injection for the acute and maintenance treatment of schizophrenia in adults.Pharmacotherapy of suicidal behavior in bipolar disorder.The metabolic syndrome and schizophrenia: a review.Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophreniaIncidence and factors associated with medication nonadherence in patients with mental illness: a cross-sectional studyGuideline-concordant antipsychotic use and mortality in schizophrenia.Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder.Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?A systematic review of psychotropic drug prescribing for prisoners.Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose.New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia.Assessing clinicians' perspectives about the identification and management of antipsychotic medication side-effects: Psychometric evaluation of a survey questionnaire.Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment.Factors associated with self-rated sexual function in Korean patients with schizophrenia receiving risperidone monotherapy.Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.A scoping review of community pharmacists and patients at risk of suicide.Assessment and treatment of suicide risk in schizophrenia.Mental health nurses' views about antipsychotic medication side effects.Are immediate- and extended-release drugs interchangeable?Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg.
P2860
Q28077687-B61CA550-46EA-4040-82EE-676415A972C5Q31035745-AE1A14D9-DF73-49C7-89B3-98E143E5E42FQ33857710-A5BA7724-FC3D-497E-9C7B-A6537BB51AD8Q34231559-F169526A-A1CE-4CAE-96EB-0C158ED54600Q34337829-ECAFD531-CD97-4D55-B6D8-38C6B7BC3479Q34588656-949D0C33-21CF-4560-BB7E-20B5C3892E5DQ36107067-D21025E1-C686-4302-8DC7-F8BB71BE25DCQ36144552-11F7D0F4-62F3-4429-B865-D0212EE2223DQ36195190-41205E3A-2E6C-4B9C-B121-234099B57108Q36272501-398959BC-05CA-46A4-9ED6-E6838F7BA01FQ36755049-E2C1CE61-1E6A-4E7F-97C8-BA95DE232EB5Q37091075-2653258D-7BEC-4547-B995-3C5488453CB4Q37131022-E8587302-B61C-46E2-9ECD-01867C222422Q37356486-16A2803F-65E6-47AF-A396-8E4EDA5516A6Q37756971-D5E836E9-DE52-4532-AAC1-CFFEB9D491D9Q37868003-699D401F-1E28-42A0-847A-39FDACF73840Q38005606-36C2F98B-3CE3-4D08-99DA-DC8249CF6C12Q38110795-602CA7EC-1273-4ECF-BDBC-101466F6B5FDQ38125213-7E2445A1-7221-4F8E-87D7-17808A73CCC9Q38719003-529FEA04-281D-4720-8719-95D28CA6115FQ38932319-A307A09D-8204-4359-88C6-6C4D44629AB3Q41629589-B14E0456-38D4-40C3-A1B9-5CFACAA3D35CQ42279135-B4689301-9C52-43A6-89B1-0834CF1041A5Q45844561-7CC1CCA1-4D0C-4ED4-B921-C2EA0B0707BBQ46844433-F677234A-476E-4372-9F84-2C3AE52D8416Q47992912-1CC9D12F-9F4D-45D5-B759-69F5BD5A7DCCQ50737084-815E0759-9413-4948-9531-E35E92070827Q51665119-2D089FFE-0A9B-43C2-983D-F2A666A8592E
P2860
Increased suicide attempt rate among patients interrupting use of atypical antipsychotics.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Increased suicide attempt rate ...... se of atypical antipsychotics.
@en
Increased suicide attempt rate ...... se of atypical antipsychotics.
@nl
type
label
Increased suicide attempt rate ...... se of atypical antipsychotics.
@en
Increased suicide attempt rate ...... se of atypical antipsychotics.
@nl
prefLabel
Increased suicide attempt rate ...... se of atypical antipsychotics.
@en
Increased suicide attempt rate ...... se of atypical antipsychotics.
@nl
P356
P1476
Increased suicide attempt rate ...... se of atypical antipsychotics.
@en
P2093
Joëlle A Erkens
Ron M Herings
P304
P356
10.1002/PDS.837
P577
2003-07-01T00:00:00Z